Literature DB >> 1218074

Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.

A Miyama, T Kato, S Horai, J Yokoo, S Kashiba.   

Abstract

A complex formed between cobra venom factor (CVF) and isolated human factor B (B) was found to be converted by trypsin to a stable enzyme, CVF-B which cleaved the third component (C3) and the fifth component (C5) of human complement. The formation of CVF-B by trypsin required divalent cations, whereas the formation of the lytic factor from human serum occurred even in the presence of EDTA. CVF-B purified by gel filtration could initiate the hemolysis of unsensitized guinea pig erythrocytes when incubated with human complement components C5 to C9 in 0.01 M EDTA buffer. C3 was not required for the lysis of guinea pig erythrocytes initiated by CVF-B because of the beta1C precipitation line formed between human serum and anti-beta1C antibody did not inhibit the hemolysis by CVF-B in agarose gel. Treatment of beta1C and beta1F globulins in whole human serum with CVF-B in the presence of 0.01 M EDTA converted them to components with higher mobilities on immunoelectrophoresis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1218074

Source DB:  PubMed          Journal:  Biken J        ISSN: 0006-2324


  5 in total

1.  The serum resistance of malaria-infected erythrocytes.

Authors:  Y Kawamoto; K Kojima; Y Hitsumoto; H Okada; V M Holers; A Miyama
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

2.  Identification of hemolytic granules isolated from human myocardial cells.

Authors:  Y Kawamoto; T Hanaichi; M Naito; A Miyama
Journal:  Experientia       Date:  1990-05-15

3.  Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase.

Authors:  C W Vogel; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

4.  H-2-linked murine factor B phenotypes.

Authors:  E S Paolucci; D C Shreffler
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.

Authors:  H Kitamura; M Tsuboi; K Nagaki
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.